Testing effectiveness (Phase 2)Study completedNCT03858686
What this trial is testing
The Effect of FP-025, on Allergen-induced Airway Responses in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma.
Who this might be right for
Asthma, COPD
Foresee Pharmaceuticals Co., Ltd. 27